US8753722037 - Common Stock
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment.
Don't give up on this healthcare stock too soon.
One product in particular could juice the company's fundamentals, a pundit believes.
Small-cap stocks have been hot and these shares discussed here are likely to heat up and double over the next year.
Chief Operating & Growth Officer Peyton Howell to succeed Jamie Macdonald effective May 15, 2024; Mr. Macdonald to retire as CEO and continue on the Board of Directors through Dec. 31, 2024
On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78.
Tandem Diabetes climbed as investors focused on its strong outlook for the coming year.
When it comes to buying dividend stocks, investors should seek out companies that consistently and repliably grow their payout over time.
Don't be too quick to ignore these stocks.
EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END
/PRNewswire/ -- The global diabetes therapy and treatment market is driven primarily by increased diabetes prevalence, sedentary lifestyles, and most other...